Insider Trading Alert - DDD, HAL, CHE, G And GSVC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 19, 2013, 167 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $93.28 to $173,250,000.00.

Highlighted Stocks Traded by Insiders:

3D Systems Corporation (DDD) - FREE Research Report

Gregoire Damon Joseph who is SVP, Chief Financial Officer at 3D Systems Corporation sold 45,000 shares at $79.99 on Nov. 19, 2013. Following this transaction, the SVP, Chief Financial Officer owned 264,000 shares meaning that the stake was reduced by 14.56% with the 45,000 share transaction.

The shares most recently traded at $72.60, down $7.39, or 10.18% since the insider transaction. Historical insider transactions for 3D Systems Corporation go as follows:

  • 4-Week # shares sold: 50,000
  • 12-Week # shares sold: 50,000
  • 24-Week # shares sold: 84,000

The average volume for 3D Systems Corporation has been 4.4 million shares per day over the past 30 days. 3D Systems Corporation has a market cap of $8.3 billion and is part of the technology sector and computer hardware industry. Shares are up 126.62% year to date as of the close of trading on Tuesday.

3D Systems Corporation, through its subsidiaries, develops, manufactures and markets 3D printers, print materials, on-demand custom parts services, and 3D authoring solutions for professionals and consumers. The company has a P/E ratio of 175.2. Currently there are 6 analysts that rate 3D Systems Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DDD - FREE

TheStreet Quant Ratings rates 3D Systems Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full 3D Systems Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Halliburton Company (HAL) - FREE Research Report

Pope Lawrence J who is EVP Administration & CHRO at Halliburton Company sold 3,000 shares at $56.40 on Nov. 19, 2013. Following this transaction, the EVP Administration & CHRO owned 161,933 shares meaning that the stake was reduced by 1.82% with the 3,000 share transaction.

The shares most recently traded at $53.88, down $2.52, or 4.68% since the insider transaction. Historical insider transactions for Halliburton Company go as follows:

  • 4-Week # shares sold: 68,096
  • 12-Week # shares sold: 154,362
  • 24-Week # shares sold: 255,728

The average volume for Halliburton Company has been 8.3 million shares per day over the past 30 days. Halliburton Company has a market cap of $46.1 billion and is part of the basic materials sector and energy industry. Shares are up 54.97% year to date as of the close of trading on Tuesday.

Halliburton Company provides a range of services and products for the exploration, development, and production of oil and natural gas to oil and gas companies worldwide. The company operates in two segments, Completion and Production, and Drilling and Evaluation. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 26.0. Currently there are 17 analysts that rate Halliburton Company a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAL - FREE

TheStreet Quant Ratings rates Halliburton Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Halliburton Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Chemed Corporation (CHE) - FREE Research Report

Mcnamara Kevin J who is president and CEO at Chemed Corporation sold 5,000 shares at $76.00 on Nov. 19, 2013. Following this transaction, the president and CEO owned 188,203 shares meaning that the stake was reduced by 2.59% with the 5,000 share transaction.

Otoole Timothy S who is executive vice president at Chemed Corporation sold 10,000 shares at $76.25 on Nov. 19, 2013. Following this transaction, the executive vice president owned 42,624 shares meaning that the stake was reduced by 19% with the 10,000 share transaction.

The shares most recently traded at $76.51, up $0.26, or 0.34% since the insider transaction. Historical insider transactions for Chemed Corporation go as follows:

  • 12-Week # shares sold: 400
  • 24-Week # shares sold: 18,400

The average volume for Chemed Corporation has been 264,100 shares per day over the past 30 days. Chemed Corporation has a market cap of $1.3 billion and is part of the health care sector and health services industry. Shares are up 11.98% year to date as of the close of trading on Tuesday.

Chemed Corporation, through its subsidiaries, operates in the healthcare, and repair and maintenance fields in the United States. The company operates in two segments, Vitas and Roto-Rooter. The stock currently has a dividend yield of 1.05%. The company has a P/E ratio of 17.9. Currently there is 1 analyst that rates Chemed Corporation a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHE - FREE

TheStreet Quant Ratings rates Chemed Corporation as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations, increase in stock price during the past year and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Chemed Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Genpact (G) - FREE Research Report

Guaglianone Victor who is SVP & General Counsel at Genpact sold 7,672 shares at $18.28 on Nov. 19, 2013. Following this transaction, the SVP & General Counsel owned 26,638 shares meaning that the stake was reduced by 22.36% with the 7,672 share transaction.

The shares most recently traded at $18.12, down $0.16, or 0.9% since the insider transaction. Historical insider transactions for Genpact go as follows:

  • 12-Week # shares sold: 15,177
  • 24-Week # shares sold: 15,177

The average volume for Genpact has been 645,900 shares per day over the past 30 days. Genpact has a market cap of $4.2 billion and is part of the services sector and diversified services industry. Shares are up 17.29% year to date as of the close of trading on Tuesday.

Genpact Limited provides business process management and information technology services worldwide. The company has a P/E ratio of 32.5. Currently there are 6 analysts that rate Genpact a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on G - FREE

TheStreet Quant Ratings rates Genpact as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Genpact Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

GSV Capital (GSVC) - FREE Research Report

Crowder David V. who is Executive Vice President at GSV Capital bought 275 shares at $11.73 on Nov. 19, 2013. Following this transaction, the Executive Vice President owned 13,825 shares meaning that the stake was reduced by 2.03% with the 275 share transaction.

The shares most recently traded at $11.75, up $0.02, or 0.17% since the insider transaction. Historical insider transactions for GSV Capital go as follows:

  • 4-Week # shares bought: 545
  • 12-Week # shares bought: 545
  • 24-Week # shares bought: 545

The average volume for GSV Capital has been 1.0 million shares per day over the past 30 days. GSV Capital has a market cap of $228.4 million and is part of the financial sector and financial services industry. Shares are up 40.21% year to date as of the close of trading on Tuesday.

GSV Capital Corp. is a BDC fund specializing in investments in emerging growth companies and venture-backed private companies. It may also invest in select publicly-traded equity securities of companies that otherwise meet its investment criteria. Currently there are 2 analysts that rate GSV Capital a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GSVC - FREE

TheStreet Quant Ratings rates GSV Capital as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, compelling growth in net income and impressive record of earnings per share growth. However, as a counter to these strengths, we find that revenues have generally been declining. Get the full GSV Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

3D Systems Could Plunge Even More

3D Systems Could Plunge Even More

Stocks Hold at Prior Levels After Fed Leaves Rates Unchanged

Stocks Hold at Prior Levels After Fed Leaves Rates Unchanged

Samsung, Apple, Qualcomm and Facebook - 5 Things You Must Know

Samsung, Apple, Qualcomm and Facebook - 5 Things You Must Know

Futures Fall as Washington Braces for Updates on Tax Reform and Mueller Probe

Futures Fall as Washington Braces for Updates on Tax Reform and Mueller Probe

Hurricanes Again Could Impact the Jobs Report in the Week Ahead

Hurricanes Again Could Impact the Jobs Report in the Week Ahead